Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$13.4M
Filings
19
Firms Hired
1
Active Period
1999–2008
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Access to Life-Saving Medicine Act
2008 · fourth_quarter · Firm: BARR PHARMACEUTICALS INC
H.R. 1038 & S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection & Innovative Biologic Medicines Act; H.R. 5629, Pathway for Biosimilars Act; S. 316, Preserve Access to Affordable Generics Act; H.R. 1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or National Drug Trafficking System; H.R. 2900, Food & Drug Administration Amendments Act; H.R. 1980 & S. 1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions (R&D Tax Credit)
Client expense: $1,560,000 · Firm income: —
Matched citations: H.R. 1038
Protecting Consumer Access to Generic Drugs Act of 2007
2008 · fourth_quarter · Firm: BARR PHARMACEUTICALS INC
H.R. 1038 & S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection & Innovative Biologic Medicines Act; H.R. 5629, Pathway for Biosimilars Act; S. 316, Preserve Access to Affordable Generics Act; H.R. 1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or National Drug Trafficking System; H.R. 2900, Food & Drug Administration Amendments Act; H.R. 1980 & S. 1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions (R&D Tax Credit)
Client expense: $1,560,000 · Firm income: —
Matched citations: H.R. 1902
Patient Protection and Innovative Biologic Medicines Act of 2007
2008 · fourth_quarter · Firm: BARR PHARMACEUTICALS INC
H.R. 1038 & S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection & Innovative Biologic Medicines Act; H.R. 5629, Pathway for Biosimilars Act; S. 316, Preserve Access to Affordable Generics Act; H.R. 1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or National Drug Trafficking System; H.R. 2900, Food & Drug Administration Amendments Act; H.R. 1980 & S. 1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions (R&D Tax Credit)
Client expense: $1,560,000 · Firm income: —
Matched citations: H.R. 1956
Housing Assistance Council Authorization Act of 2007
2008 · fourth_quarter · Firm: BARR PHARMACEUTICALS INC
H.R. 1038 & S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection & Innovative Biologic Medicines Act; H.R. 5629, Pathway for Biosimilars Act; S. 316, Preserve Access to Affordable Generics Act; H.R. 1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or National Drug Trafficking System; H.R. 2900, Food & Drug Administration Amendments Act; H.R. 1980 & S. 1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions (R&D Tax Credit)
Client expense: $1,560,000 · Firm income: —
Matched citations: H.R. 1980
Food and Drug Administration Amendments Act of 2007
2008 · fourth_quarter · Firm: BARR PHARMACEUTICALS INC
H.R. 1038 & S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection & Innovative Biologic Medicines Act; H.R. 5629, Pathway for Biosimilars Act; S. 316, Preserve Access to Affordable Generics Act; H.R. 1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or National Drug Trafficking System; H.R. 2900, Food & Drug Administration Amendments Act; H.R. 1980 & S. 1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions (R&D Tax Credit)
Client expense: $1,560,000 · Firm income: —
Matched citations: H.R. 2900
Pathway for Biosimilars Act
2008 · fourth_quarter · Firm: BARR PHARMACEUTICALS INC
H.R. 1038 & S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection & Innovative Biologic Medicines Act; H.R. 5629, Pathway for Biosimilars Act; S. 316, Preserve Access to Affordable Generics Act; H.R. 1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or National Drug Trafficking System; H.R. 2900, Food & Drug Administration Amendments Act; H.R. 1980 & S. 1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions (R&D Tax Credit)
Client expense: $1,560,000 · Firm income: —
Matched citations: H.R. 5629
Patent Reform Act of 2007
2008 · fourth_quarter · Firm: BARR PHARMACEUTICALS INC
H.R. 1038 & S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection & Innovative Biologic Medicines Act; H.R. 5629, Pathway for Biosimilars Act; S. 316, Preserve Access to Affordable Generics Act; H.R. 1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or National Drug Trafficking System; H.R. 2900, Food & Drug Administration Amendments Act; H.R. 1980 & S. 1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions (R&D Tax Credit)
Client expense: $1,560,000 · Firm income: —
Matched citations: S. 1145
Preserve Access to Affordable Generics Act
2008 · fourth_quarter · Firm: BARR PHARMACEUTICALS INC
H.R. 1038 & S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection & Innovative Biologic Medicines Act; H.R. 5629, Pathway for Biosimilars Act; S. 316, Preserve Access to Affordable Generics Act; H.R. 1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or National Drug Trafficking System; H.R. 2900, Food & Drug Administration Amendments Act; H.R. 1980 & S. 1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions (R&D Tax Credit)
Client expense: $1,560,000 · Firm income: —
Matched citations: S. 316
Access to Life-Saving Medicine Act
2008 · fourth_quarter · Firm: BARR PHARMACEUTICALS INC
H.R. 1038 & S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection & Innovative Biologic Medicines Act; H.R. 5629, Pathway for Biosimilars Act; S. 316, Preserve Access to Affordable Generics Act; H.R. 1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or National Drug Trafficking System; H.R. 2900, Food & Drug Administration Amendments Act; H.R. 1980 & S. 1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions (R&D Tax Credit)
Client expense: $1,560,000 · Firm income: —
Matched citations: S. 623
Access to Life-Saving Medicine Act
2008 · third_quarter · Firm: BARR PHARMACEUTICALS INC
H.R.1038 & S.623, Access to Life-Saving Medicine Act; H.R.1956, Patient Protection & Innvoative Biologic Medicines Act; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; H.R.1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or Nat'l Drug Trafficking Sytems; H.R.2900, Food & Drug Administration Amendments Act; H.R.1908 & S.1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions for R&D Tax Credit.
Client expense: $1,530,000 · Firm income: —
Matched citations: H.R.1038
Protecting Consumer Access to Generic Drugs Act of 2007
2008 · third_quarter · Firm: BARR PHARMACEUTICALS INC
H.R.1038 & S.623, Access to Life-Saving Medicine Act; H.R.1956, Patient Protection & Innvoative Biologic Medicines Act; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; H.R.1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or Nat'l Drug Trafficking Sytems; H.R.2900, Food & Drug Administration Amendments Act; H.R.1908 & S.1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions for R&D Tax Credit.
Client expense: $1,530,000 · Firm income: —
Matched citations: H.R.1902
Patent Reform Act of 2007
2008 · third_quarter · Firm: BARR PHARMACEUTICALS INC
H.R.1038 & S.623, Access to Life-Saving Medicine Act; H.R.1956, Patient Protection & Innvoative Biologic Medicines Act; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; H.R.1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or Nat'l Drug Trafficking Sytems; H.R.2900, Food & Drug Administration Amendments Act; H.R.1908 & S.1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions for R&D Tax Credit.
Client expense: $1,530,000 · Firm income: —
Matched citations: H.R.1908
Patient Protection and Innovative Biologic Medicines Act of 2007
2008 · third_quarter · Firm: BARR PHARMACEUTICALS INC
H.R.1038 & S.623, Access to Life-Saving Medicine Act; H.R.1956, Patient Protection & Innvoative Biologic Medicines Act; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; H.R.1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or Nat'l Drug Trafficking Sytems; H.R.2900, Food & Drug Administration Amendments Act; H.R.1908 & S.1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions for R&D Tax Credit.
Client expense: $1,530,000 · Firm income: —
Matched citations: H.R.1956
Food and Drug Administration Amendments Act of 2007
2008 · third_quarter · Firm: BARR PHARMACEUTICALS INC
H.R.1038 & S.623, Access to Life-Saving Medicine Act; H.R.1956, Patient Protection & Innvoative Biologic Medicines Act; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; H.R.1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or Nat'l Drug Trafficking Sytems; H.R.2900, Food & Drug Administration Amendments Act; H.R.1908 & S.1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions for R&D Tax Credit.
Client expense: $1,530,000 · Firm income: —
Matched citations: H.R.2900
Pathway for Biosimilars Act
2008 · third_quarter · Firm: BARR PHARMACEUTICALS INC
H.R.1038 & S.623, Access to Life-Saving Medicine Act; H.R.1956, Patient Protection & Innvoative Biologic Medicines Act; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; H.R.1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or Nat'l Drug Trafficking Sytems; H.R.2900, Food & Drug Administration Amendments Act; H.R.1908 & S.1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions for R&D Tax Credit.
Client expense: $1,530,000 · Firm income: —
Matched citations: H.R.5629
H.R.1038 & S.623, Access to Life-Saving Medicine Act; H.R.1956, Patient Protection & Innvoative Biologic Medicines Act; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; H.R.1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or Nat'l Drug Trafficking Sytems; H.R.2900, Food & Drug Administration Amendments Act; H.R.1908 & S.1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions for R&D Tax Credit.
Client expense: $1,530,000 · Firm income: —
Matched citations: S.1145
Preserve Access to Affordable Generics Act
2008 · third_quarter · Firm: BARR PHARMACEUTICALS INC
H.R.1038 & S.623, Access to Life-Saving Medicine Act; H.R.1956, Patient Protection & Innvoative Biologic Medicines Act; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; H.R.1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or Nat'l Drug Trafficking Sytems; H.R.2900, Food & Drug Administration Amendments Act; H.R.1908 & S.1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions for R&D Tax Credit.
Client expense: $1,530,000 · Firm income: —
Matched citations: S.316
Access to Life-Saving Medicine Act
2008 · third_quarter · Firm: BARR PHARMACEUTICALS INC
H.R.1038 & S.623, Access to Life-Saving Medicine Act; H.R.1956, Patient Protection & Innvoative Biologic Medicines Act; H.R.5629, Pathway for Biosimilars Act; S.316, Preserve Access to Affordable Generics Act; H.R.1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or Nat'l Drug Trafficking Sytems; H.R.2900, Food & Drug Administration Amendments Act; H.R.1908 & S.1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions for R&D Tax Credit.
Client expense: $1,530,000 · Firm income: —
Matched citations: S.623
Access to Life-Saving Medicine Act
2008 · second_quarter · Firm: BARR PHARMACEUTICALS INC
H.R. 1038 & S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection & Innovative Biologic Medicines Act; H.R. 5629, Pathway for Biosimilars Act; S. 316, Preserve Access to Affordable Generics Act; H.R. 1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or National Drug Trafficking System; H.R. 2900, Food & Drug Adminsitration Amendments Act; H.R. 1908 & S. 1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions - R&D Tax Credit
Client expense: $1,530,000 · Firm income: —
Matched citations: H.R. 1038
Protecting Consumer Access to Generic Drugs Act of 2007
2008 · second_quarter · Firm: BARR PHARMACEUTICALS INC
H.R. 1038 & S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection & Innovative Biologic Medicines Act; H.R. 5629, Pathway for Biosimilars Act; S. 316, Preserve Access to Affordable Generics Act; H.R. 1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or National Drug Trafficking System; H.R. 2900, Food & Drug Adminsitration Amendments Act; H.R. 1908 & S. 1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions - R&D Tax Credit
Client expense: $1,530,000 · Firm income: —
Matched citations: H.R. 1902
Patent Reform Act of 2007
2008 · second_quarter · Firm: BARR PHARMACEUTICALS INC
H.R. 1038 & S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection & Innovative Biologic Medicines Act; H.R. 5629, Pathway for Biosimilars Act; S. 316, Preserve Access to Affordable Generics Act; H.R. 1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or National Drug Trafficking System; H.R. 2900, Food & Drug Adminsitration Amendments Act; H.R. 1908 & S. 1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions - R&D Tax Credit
Client expense: $1,530,000 · Firm income: —
Matched citations: H.R. 1908
Patient Protection and Innovative Biologic Medicines Act of 2007
2008 · second_quarter · Firm: BARR PHARMACEUTICALS INC
H.R. 1038 & S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection & Innovative Biologic Medicines Act; H.R. 5629, Pathway for Biosimilars Act; S. 316, Preserve Access to Affordable Generics Act; H.R. 1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or National Drug Trafficking System; H.R. 2900, Food & Drug Adminsitration Amendments Act; H.R. 1908 & S. 1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions - R&D Tax Credit
Client expense: $1,530,000 · Firm income: —
Matched citations: H.R. 1956
Food and Drug Administration Amendments Act of 2007
2008 · second_quarter · Firm: BARR PHARMACEUTICALS INC
H.R. 1038 & S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection & Innovative Biologic Medicines Act; H.R. 5629, Pathway for Biosimilars Act; S. 316, Preserve Access to Affordable Generics Act; H.R. 1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or National Drug Trafficking System; H.R. 2900, Food & Drug Adminsitration Amendments Act; H.R. 1908 & S. 1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions - R&D Tax Credit
Client expense: $1,530,000 · Firm income: —
Matched citations: H.R. 2900
Pathway for Biosimilars Act
2008 · second_quarter · Firm: BARR PHARMACEUTICALS INC
H.R. 1038 & S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection & Innovative Biologic Medicines Act; H.R. 5629, Pathway for Biosimilars Act; S. 316, Preserve Access to Affordable Generics Act; H.R. 1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or National Drug Trafficking System; H.R. 2900, Food & Drug Adminsitration Amendments Act; H.R. 1908 & S. 1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions - R&D Tax Credit
Client expense: $1,530,000 · Firm income: —
Matched citations: H.R. 5629
Patent Reform Act of 2007
2008 · second_quarter · Firm: BARR PHARMACEUTICALS INC
H.R. 1038 & S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection & Innovative Biologic Medicines Act; H.R. 5629, Pathway for Biosimilars Act; S. 316, Preserve Access to Affordable Generics Act; H.R. 1902, Protecting Consumer Access to Generic Drugs Act; Development of "Pedigree" or National Drug Trafficking System; H.R. 2900, Food & Drug Adminsitration Amendments Act; H.R. 1908 & S. 1145, Patent Reform Act; FDA Globalization Act; Tax Incentives/Extensions - R&D Tax Credit
Client expense: $1,530,000 · Firm income: —
Matched citations: S. 1145
Source: Senate LDA